Skip to Content

54 213 54 213 (Lithium Carbonate 150 mg)

Pill with imprint 54 213 54 213 is White, Capsule-shape and has been identified as Lithium Carbonate 150 mg. It is supplied by Roxane Laboratories, Inc..

Lithium is used in the treatment of bipolar disorder; schizoaffective disorder; mania and belongs to the drug class antimanic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 54 213 54 213

Lithium carbonate 150 mg 54 213 54 213
Lithium carbonate 150 mg 54 213 54 213
Lithium carbonate 150 mg 54 213 54 213
Lithium carbonate 150 mg 54 213 54 213

Lithium Carbonate

Imprint
54 213 54 213
Strength
150 mg
Color
White
Size
12.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antimanic agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Roxane Laboratories, Inc.
Inactive Ingredients
FD&C Red No. 40, sodium lauryl sulfate, magnesium silicate, titanium dioxide, ferrosoferric oxide, povidone k30, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00054-8526 Roxane Laboratories, Inc.
00054-2526 Roxane Laboratories, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.